ConvEyXO
PrivateLast Round
Seed
Jul 1, 2019
Total Funding Raised
$1.12M
Company Overview
ConvEyXO is a biotechnology company developing a therapeutic portfolio in anti-inflammatory and aging-related diseases built on a proprietary technology platform that harnesses engineered exosomes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ConvEyXO Comparables
Compare ConvEyXO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EXO Biologics | 85% | |
| EVerZom | 84% | |
| Curexsys GmbH | 81% | |
ConvEyXO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 1, 2019 |
ConvEyXO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sambrinvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Grew 20% QoQ, from 15 to 18 employees.
- Jan 7, 2026
Monthly visitors increased 545% MoM.
ConvEyXO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ConvEyXO's valuation, stock price, and market status.